Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA). In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus. CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.
So far about 124 positive cases have been reported in a host of countries, including India where the first case was confirmed in Kerala.
The coronavirus outbreak began in Wuhan, capital of China's Hubei province, in December and has now spread across the globe. The Chinese authorities are trying to contain the epidemic while other countries, including India, are working on plans to evacuate their citizens from Wuhan and other cities in Hubei province, the epicentre of the outbreak.
It has triggered a cause of concern for India too as many of the 700 odd Indian students studying in universities of Wuhan and Hubei provinces are still stuck up there.
China on Sunday ruled out allowing open nominations in elections for the Hong Kong's next leader, in a move that could ignite tension in the Asian financial hub where the democracy advocates have threatened to shut down the main business district in protest.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances